However, MYCN amplification in neuroblastoma causes resistance to chemotherapy, associated with tumor progression and poor prognosis[36]: this suggests that MYCN-induced apoptosis may be inhibited by an additional oncogenic mechanism, crucial for tumor progression. The gene discussed is MYCN; the disease is neuroblastoma.